Search filters

List of works by Jörn M Schattenberg

A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development

scientific article published on September 2017

Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.

scientific article

Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors.

scientific article published on 24 October 2014

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

scientific article published on 24 February 2012

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

scientific article published on 05 March 2020

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

scientific article

Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome

scientific article published on 12 February 2011

Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis

scientific article published on 10 October 2018

Apoptosis in liver disease

scientific article published on 01 October 2006

Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials.

scientific article

Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbers

scientific article published on 04 July 2019

Association between diabetes mellitus and hepatic encephalopathy in patients with liver cirrhosis

scientific article published on 29 June 2020

Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study

scientific article published on 07 January 2021

CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling.

scientific article published on February 2004

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein Cholesterol

scientific article published on 30 September 2019

Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.

scientific article published on January 2011

Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohort

scientific article published in 2022

Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study

scientific article published on 11 November 2016

Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure

scientific article published on 14 December 2015

Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents.

scientific article published on 12 October 2013

Disclosure behaviour and experienced reactions in patients with HIV versus chronic viral hepatitis or diabetes mellitus in Germany

scientific article published on 5 February 2013

Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma

scientific article published on February 22, 2013

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.

scientific article

Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir

scientific article published on 3 October 2015

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort

scientific article published on 4 August 2015

Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply

scientific article published on 01 December 2018

Effectiveness of lifestyle interventions in NAFLD (nonalcoholic fatty liver disease) - how are clinical trials affected?

scientific article published on 21 January 2020

Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis.

scientific article

Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis

scientific article published on 05 May 2020

Epidemiology of hepatic encephalopathy in german hospitals - the EpHE study.

scientific article published on 12 July 2017

Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis

scientific article published on 27 February 2016

Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors

scientific article published on 9 July 2016

Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation

scientific article published on 28 July 2016

Hepatocyte resistance to oxidative stress is dependent on protein kinase C-mediated down-regulation of c-Jun/AP-1.

scientific article published on 15 May 2004

Hepatocyte-specific deletion of IL1-RI attenuatesliver injury by blocking IL-1 driven autoinflammation

scientific article published on 20 January 2018

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

scientific article published on 4 July 2017

Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany

scientific article published on 03 December 2019

Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program

scientific article published on 25 July 2019

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany

scientific article published on 10 October 2020

Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

scientific article published on 19 September 2014

Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP

scientific article published on 14 June 2012

Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease.

scientific article published on 25 May 2015

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

scientific article published in January 2006

Leptomeningeal familial amyloidosis: A rare differential diagnosis of leptomeningeal enhancement in MRI

scientific article published on 21 September 2006

Liver injury in COVID-19: The current evidence

scientific article published on 01 June 2020

Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)

scientific article published on 24 March 2010

Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct-ligation.

scientific article

Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.

scientific article published on 18 December 2017

Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation

scientific article published on 05 November 2012

Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH

scientific article published on 01 May 2019

NAFLD - sounding the alarm on a silent epidemic

scientific article published on 08 June 2020

NAFLD between genes and environment: what drives fibrogenesis?

scientific article published on 05 August 2020

New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factor

scientific article published on 6 June 2015

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease

scientific article published on 23 July 2020

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

scientific article published on August 2013

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression

scientific article published on 22 June 2020

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)

scientific article published on 11 March 2019

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

scientific article published on 12 February 2016

Patterns of liver injury in COVID-19 - a German case series

scientific article published on 26 June 2020

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

article

Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

scientific article published on 23 March 2020

Prime time for medical therapy in NASH?

scientific article published on 5 December 2016

Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH)

scientific article published on 03 February 2020

Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study

scientific article published on 30 July 2020

Reading the stars for hepatic fibrosis or how to predict the severity of liver disease in patients with NASH

scientific article published on 01 May 2019

Refining Noninvasive Diagnostics In Nonalcoholic Fatty Liver Disease: Closing the Gap to Detect Advanced Fibrosis

scientific article published on 08 February 2019

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling.

scientific article

Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.

scientific article published in July 2009

S2k Guideline non-alcoholic fatty liver disease

scientific article published on 13 July 2015

Shortcut to death

scientific article published on 01 December 2009

Show me your signaling--and I'll tell you who you are

scientific article published on 27 May 2009

Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)

scientific article published on 18 December 2019

The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm

scientific article published on 04 July 2017

The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease

scientific article

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

scientific article published in September 2023

The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success

scientific article published on 19 October 2020

The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.

scientific article

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

scientific article published on 01 December 2020

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

scientific article published on April 2015

Treatment of malignant ascites with a second cycle of catumaxomab in gastric signet cell carcinoma--a report of 2 cases

scientific article published on 28 July 2014

Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance-associated substitutions

scientific article published on 08 July 2020

Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu

scientific article published on 22 June 2017

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters – an animal model of life style intervention in NAFLD

scientific article published on 08 March 2019

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study

scientific article published on 02 January 2019

[Acute liver failure--medical viewpoints]

scientific article published on 01 November 2006

[Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure]

scientific article published on 01 December 2015

[Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature]

scientific article published on 13 January 2014

[Etiology and complications of liver cirrhosis: data from a German centre].

scientific article

[Expected increase of hepatocellular carcinoma by nonalcoholic fatty liver disease]

scientific article published on 07 April 2016

[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology].

scientific article

[Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]

scientific article published on 08 December 2020

[Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?]

scientific article published on 13 July 2015

[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome]

scientific article published on 22 January 2015